Allergan Inc. v. Juno Pharmaceuticals Corp. re: LUMIGAN RC®

Represented AbbVie and Allergan in a successful patent infringement action brought under the Patented Medicines (Notice of Compliance) Regulations in relation to the ophthalmic drug LUMIGAN RC® in which Allergan's patents were held to be valid and infringed.